| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/04/2007 | US20070003580 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003536 Using a grapefruit, grape seed and green tea extract comprising superoxide dismutase, glutathione, tetrahydrodiferuloylmethane, flavonoid, tocopherol and tocopheryl acetate as part of lotion to treat and prevent damaged skin |
| 01/04/2007 | US20070003533 Inhibition of the beta3 subunit of L-type Ca2+ channels |
| 01/04/2007 | US20070003502 Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose |
| 01/04/2007 | CA2619503A1 Aromatase inhibitors for emergency contraception |
| 01/04/2007 | CA2613617A1 Compositions and methods for enhancement of sexual function |
| 01/04/2007 | CA2609336A1 Quadraphasic continuous graduated estrogen contraceptive |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739173A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1738767A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 01/03/2007 | EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain |
| 01/03/2007 | EP1738759A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738751A2 Spaced drug delivery system |
| 01/03/2007 | EP1738253A2 Systems and methods for providing a stem cell bank |
| 01/03/2007 | EP1737502A2 Polymer no donor predrug nanofiber coating for medical devices and therapy |
| 01/03/2007 | EP1737493A2 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumour cell growth |
| 01/03/2007 | EP1737488A1 Treatment of fungal infections |
| 01/03/2007 | EP1737480A2 Pharmaceutical combined preparation containing a therapeutic protein |
| 01/03/2007 | EP1737475A1 Herbal therapy for the treatment of asthma |
| 01/03/2007 | EP1737473A2 Lithium combinations, and uses related thereto |
| 01/03/2007 | EP1737467A1 Method and composition for treatment of skin conditions |
| 01/03/2007 | EP1737466A1 COMBINATION OF y-AMINOBUTYRIC ACID MODULATORS AND 5-HT-1b RECEPTOR ANTAGONISTS |
| 01/03/2007 | EP1737452A1 Angiogenesis-affecting compounds and methods of use thereof |
| 01/03/2007 | EP1737443A2 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils |
| 01/03/2007 | EP1737438A1 alpha-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS |
| 01/03/2007 | EP1737412A2 Use of sulfated hyaluronic acid |
| 01/03/2007 | EP1633394B1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 01/03/2007 | EP1562492B1 Apparatus for the detection and occlusion of blood vessels |
| 01/03/2007 | EP1509230B1 Gefitinib (iressa) for the treatment of cancer |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1448168B1 Pharmaceutical formulation comprising bicalutamide |
| 01/03/2007 | EP1411889B1 Cream for treatment of skin injured by the sun |
| 01/03/2007 | EP1390040B1 Pharmaceutical composition for use in hormone replacement therapy |
| 01/03/2007 | EP1383514B1 Use of a composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1322292B1 Microparticle compositions and methods for the manufacture thereof |
| 01/03/2007 | EP1304371B1 Cds1 knockout mice and cell lines established thereof |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1221865B1 Food supplement for increasing lean mass and strength |
| 01/03/2007 | EP1210116B1 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 01/03/2007 | EP1108435B1 Preventives or remedies for pancreatitis containing anti-il-6 receptor antibodies as the active ingredient |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | EP1082106B1 Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl |
| 01/03/2007 | EP1044014B9 Agent for treating allergic or hypersensitivity condition |
| 01/03/2007 | CN1890295A Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 01/03/2007 | CN1889956A Methods and reagents for the treatment of immunoinflammatory disorders |
| 01/03/2007 | CN1889952A Combination of (a) n-[5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl]-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof |
| 01/03/2007 | CN1887352A Composition for treating eye's fungal and bacterial infection |
| 01/03/2007 | CN1887269A Slow released anticancer injection containing bendamustine and its synergist |
| 01/03/2007 | CN1887268A Slow released anticancer injection |
| 01/03/2007 | CN1887267A Slow released anticancer prepn with angiogenesis inhibitor and bendamustine |
| 01/03/2007 | CN1887266A Slow released compound anticancer prepn |
| 01/03/2007 | CN1887265A Slow released anticancer prepn |
| 01/03/2007 | CN1887264A Slow released compound anticancer prepn containing bendamustine |
| 01/03/2007 | CN1887263A Slow released compound anticancer injection containing bendamustine |
| 01/03/2007 | CN1887262A Slow released anticancer medicine injection containing bendamustine and its synergist |
| 01/03/2007 | CN1887261A Slow released compound anticancer injection containing bendamustine |
| 01/03/2007 | CN1887260A Slow released compound anticancer injection containing clorfarabine |
| 01/03/2007 | CN1887259A Slow released compound anticancer prepn containing clorfarabine |
| 01/03/2007 | CN1887258A Slow released compound anticancer injection containing clorfarabine |
| 01/03/2007 | CN1887254A Precursor micelle prepn and its production process |
| 01/03/2007 | CN1293044C Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR) |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292795C Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/03/2007 | CN1292745C The treatment of respiratory diseases |
| 01/03/2007 | CN1292721C Drug delivery device |
| 01/02/2007 | US7157594 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea |
| 01/02/2007 | US7157584 Benzimidazole derivative and use thereof |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/02/2007 | US7157570 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157494 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157472 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157429 Method of regulating glucose metabolism, and reagents related thereto |
| 01/02/2007 | US7157418 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157224 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 01/02/2007 | US7157099 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 01/02/2007 | US7157089 A fusion protein containing an antigen of an influenza virus and a bacterial stress protein; vaccines induce a cytolytic T-cell (CTL) response in a mammal |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 01/02/2007 | US7157080 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 01/02/2007 | CA2368615C Thiadiazolyl urea or thiourea derivatives for antiviral treatment |